ASST trades 99.7% below Wall Street's consensus target of $34.25.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ASST achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 19, 2026, Strive, Inc. (ASST) has a Wall Street consensus price target of $34.25, based on estimates from 5 covering analysts. With the stock currently trading at $17.15, this represents a potential upside of +99.7%. The company has a market capitalization of $1.44B.
Analyst price targets range from a low of $30.00 to a high of $38.00, representing a 23% spread in expectations. The median target of $34.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ASST trades at a trailing P/E of -3.6x. Analysts expect EPS to grow +87.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $0.58, with bear and bull scenarios of $0.37 and $0.77 respectively. Model confidence stands at 38/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
COHNCohen & Company Inc. | $29M | $9.00 | — | — | — | — | — |
GROWU.S. Global Investors, Inc. | $33M | $2.57 | — | — | — | — | — |
BLKBlackRock, Inc. | $181.2B | $1169.21 | $1341.45 | +14.7% | Buy | 20.2x | 33 |
IVZInvesco Ltd. | $12.7B | $28.65 | $33.80 | +18.0% | Hold | 10.3x | 28 |
AMGAffiliated Managers Group, Inc. | $10.4B | $392.63 | $425.00 | +8.2% | Buy | 10.6x | 12 |
VRTSVirtus Investment Partners, Inc. | $751M | $112.32 | $118.50 | +5.5% | Hold | 5.0x | 11 |
NDAQNasdaq, Inc. | $59.1B | $105.72 | $112.57 | +6.5% | Buy | 25.5x | 36 |
ICEIntercontinental Exchange, Inc. | $96.9B | $171.81 | $183.89 | +7.0% | Buy | 21.0x | 36 |
MSCIMSCI Inc. | $46.3B | $636.90 | $687.70 | +8.0% | Buy | 32.3x | 27 |
CBOECboe Global Markets, Inc. | $37.7B | $359.91 | $345.83 | -3.9% | Buy | 25.1x | 31 |
Quick answers to the most common questions about buying ASST stock.
The consensus Wall Street price target for ASST is $34.25, representing 99.7% upside from the current price of $17.15. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ASST has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $34.25 implies 99.7% upside from current levels.
ASST's current price is $17.15 with a consensus target of $34.25 (99.7% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $38 for ASST, while the most conservative target is $30. The consensus of $34.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $1 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ASST is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ASST stock forecast based on 5 Wall Street analysts shows a consensus price target of $34.25, with estimates ranging from $30 (bear case) to $38 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $1, with bear/bull scenarios of $0/$1.
Our quantitative valuation model calculates ASST's fair value at $1 (base case), with a bear case of $0 and bull case of $1. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 38/100.
Wall Street analysts are very optimistic on ASST, with a "Buy" consensus rating and $34.25 price target (99.7% upside). 5 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ASST analyst price targets range from $30 to $38, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $34.25 consensus represents the middle ground. Our model's $0-$1 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.